Nanospheres encapsulating anti-leishmanial drugs for their specific macrophage targeting, reduced toxicity, and deliberate intracellular release

Vector-Borne and Zoonotic Diseases

Volumn 12, Issue 11, 2012, Pages 953-960

  Shukla, Anil Kumar ^a   Patra, Sanjukta ^a   Dubey, Vikash Kumar ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

Author keywords

Drug; Leishmaniasis; Nanoparticle; Proteins

Indexed keywords

DOXORUBICIN; METHOXYPOLY(ETHYLENE GLYCOL) B POLY(LACTIC ACID); MITOMYCIN C; NANOCARRIER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG TARGETING; EPIFLUORESCENCE MICROSCOPY; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; IN VITRO STUDY; MACROPHAGE; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SLOW DRUG RELEASE; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; LEISHMANIA; MACROPHAGES; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MITOMYCIN; NANOPARTICLES; NANOSPHERES; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; POLYMERS; X-RAY DIFFRACTION;

EID: 84869027114     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2011.0948     Document Type: Article

References (33)

1. Bally MB, Lim H, Cullis PR, et al. Controlling the drug delivery attributes of lipid- based drug formulations. J Liposome Res 1998; 8:299-335. (Pubitemid 28462812)
2. Brigger I, Dubernet C, Couvreur P. NPs in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002; 54:631-651.
3. Cheng J, Teply BA, Sherifi I, et al. Formulation of functionalized PLGA-PEG NPs for in vivo targeted drug delivery. Biomaterials 2007; 28:869-876. (Pubitemid 44667020)
4. Desai MP, Labhasetwar V, Walter E, et al. The mechanism of uptake of biodegradable microparticles in CaCO-2 cells is size dependent. Pharm Res 1997; 14:1568-1573. (Pubitemid 28009208)
5. Desjeux P. Human leishmaniases: epidemiology and public health aspects. World Health Stat 1992; 45:267-275.
6. Dirix LY, Libura M, Libura J, et al. In vitro toxicity studies with mitomycins and bleomycin on endothelial cells. Anti-Cancer Drugs 1997; 8:859-868. (Pubitemid 27487800)
7. Dong Y, Feng SS. Methoxy poly (ethylene glycol)-poly (lactide) (MPEG-PLA) NPs for controlled delivery of anticancer drug. Biomaterials 2004; 25:2843-2849.
8. Fessi H, Puisieux F, Devissaguet JP, et al. Nanocapsules formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989; 55:25-28.
9. Frank G, Langer R, Farokhzad OC. Precise engineering of targeted NPs by using self assembled biointegrated block copolymers. PNAS 2008; 105:2586.
10. Gordon S. The macrophage. BioEssays 1995; 17:977-986.
11. Gref R, Domb A, Quellec P, et al. The controlled intravenous delivery of drugs using PEG-ciated sterically stabilized nanospheres. Adv Drug Deliv Rev 1995; 16:215-233.
12. Gupta S, Pal A, Vyas SP. Drug delivery strategies for therapy of visceral leishmaniasis. Expert Opin Drug Deliv 2010; 7: 371-402.
13. Jones MC, Leroux JC. Polymeric micelle - a new generation of colloidal drug carriers. Eur J Pharm Biopharm 1995; 48:101-111.
14. Kedzierski L, Zh Y, Handman E. Leishmania vaccines: Progress and problems. Parasitol 2006; 133:S87-S112. (Pubitemid 46208033)
15. Lundberg B, Griffiths G, Hansen HJ. Cellular association and cytotoxicity of anti-CD74-targeted lipid drug-carriers in B lymphoma cells. J Control Rel 2004; 94:155-161. (Pubitemid 37542385)
16. McLennan IJ, Lenkinski RE, Yanuka Y. A nuclear magnetic resonance study of the self association of adriamycin and daunomycin in aqueous solution. Can J Chem 1985; 63:1233- 1238. (Pubitemid 15060308)
17. Menozzi M, Valentini L, Vannini E, et al. Self association of doxorubicin and related compounds in aqueous solution. J Pharm Sci 1984; 73:766-770. (Pubitemid 14122790)
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63. (Pubitemid 14203433)
19. Muriel P, Abdelkader L, Hatem F, et al. Pentamidine loaded poly (D, L-lactide) NPs: adsorption and drug release. Drug Dev Res 1998; 43:98-104.
20. Myler P, Fasel N. Leishmania: after the genome. In: Norfolk: Caister Academic, 2008.
21. Ofec I, Goldhar J, Keisari Y, et al. Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol 1995; 49:239-276.
22. Panyam J, Labhasetwar V. Biodegradable NPs for drug and gene delivery to cells and tissues. Adv Drug Deliv Rev 2003; 55: 329-347. (Pubitemid 36297053)
23. Righetti PG. Charge-state and charge-continuum models in electrophoresis and isoelectric focusing of genetic variants. J Chromatogr 1979; 173:1-5. (Pubitemid 9174003)
24. Service RF. Nanotechnology takes aim at cancer. Science 2005; 310:1132-1134. (Pubitemid 41681730)
25. Sett R, Basu N, Ghosh AK, Das PK. Potential of doxorubicin as an antilieshmanial agent. J Parasitol 1992; 78:350-354.
26. Shukla AK, Patra S, Dubey VK. Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative chemotherapy of leishmaniasis. Mol Cell Biochem 2011; 352:261-270.
27. Shukla AK, Singh BK, Patra S, et al. Rational approaches for drug designing against leishmaniasis. Appl Biochem Biotechnol 2010; 160:2208-2218.
28. Tardi PG, Boman NL, Cullis PR. Liposomal doxorubicin. J Drug Target 1996; 4:129-140. (Pubitemid 26390295)
29. Torchilinn VP, Trubetskoy VS. Which polymers can make nanoparticulate drug carriers long- circulating? Adv Drug Deliv Rev 1995; 16:141-155.
30. Xiao RZ, Zeng ZW, Zhou GL, et al. Recent advances in PEG-PLA block copolymer NPs. Int J Nanomedicine 2010; 5:1057-1065.
31. Yi Y, Kim JH, Kang HW, et al. A polymeric NP consisting of mPEG- PLA-Toco and PLMA-COONa as a drug carrier: Improvements in cellular uptake and biodistribution. Pharma Res 2005; 22:200-208. (Pubitemid 40487203)
32. Yokoyama M, Fukushima S, Uchara R, et al. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Contol Rel 1998; 50:79-92. (Pubitemid 28044103)
33. Zheng X, Kan B, Gou M, et al. Preparation of MPEG-PLA NP for honokiol delivery in vitro. Int J Pharm 2010; 386:262-267.